The resulting effect of the decreased SIRT1 was that there was also a suppression and downregulation of FOXO3, which in turn increased NFkB, resulting in pro-inflammatory responses in human bronchial epithelial cells in COPD patients [89,90]. The gene discussed is NFKB1; the disease is chronic obstructive pulmonary disease.